Transgender and Nonbinary Individuals’ Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study
- 1 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 17 (9) , e011024
Abstract
BACKGROUND: Transgender and nonbinary individuals face substantial cardiovascular health uncertainties. The use of gender-affirming hormone therapy can be used to achieve one’s gender-affirming goals. As self-rated health is an important predictor of health outcomes, an understanding of how this association is perceived by transgender and nonbinary individuals using gender-affirming hormone therapy is required. The objective of this research was to explore transgender and nonbinary individuals’ perceptions of cardiovascular health in the context of using gender-affirming hormone therapy. METHODS: In this qualitative study, English-speaking transgender and nonbinary adults using gender-affirming hormone therapy for 3 months or more were recruited from across Canada using purposive and snowball sampling methods. Semistructured interviews were conducted through videoconference to explore transgender and nonbinary individuals’ perceptions of the association between gender-affirming hormone therapy and cardiovascular health between May and August 2023. Data were transcribed verbatim, and transcripts were analyzed independently by 3 reviewers using thematic analysis. RESULTS: Twenty-one participants were interviewed (8 transgender women, 9 transgender men, and 3 nonbinary individuals; median [range] age, 27 [20–69] years; 80% White participants). Three main themes were identified: cardiovascular health was not a primary concern in the decision-making process with regard to gender-affirming hormone therapy, the improved well-being associated with gender-affirming hormone therapy was felt to contribute to improved cardiovascular health, and health care provider knowledge and attitude facilitate the transition process. CONCLUSIONS: Gender-affirming hormone therapy in transgender and nonbinary individuals is perceived to improve cardiovascular health. Given the positive associations between care aligned with patient priorities, self-rated health, and health outcomes, these findings should be considered as part of shared decision-making and person-centered care.Keywords
This publication has 56 references indexed in Scilit:
- Transgender Patient Preferences When Discussing Gender in Health Care SettingsJAMA Network Open, 2024
- The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic ReviewEndocrine Practice, 2023
- Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic ReviewEndocrine Practice, 2022
- Mobile Health Technology to Improve Care for Patients With Atrial FibrillationJACC, 2020
- Trauma-Informed Care of Sexual and Gender Minority Patients2019
- Association Between Self-rated Health, Coronary Artery Calcium Scores, and Atherosclerotic Cardiovascular Disease RiskJAMA Network Open, 2019
- Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18–39 YearsAmerican Journal of Preventive Medicine, 2018
- Saturation in qualitative research: exploring its conceptualization and operationalizationQuality & Quantity, 2017
- Association Between Gender Minority Status and Self-Reported Physical and Mental Health in the United StatesJAMA Internal Medicine, 2017
- Lesbian, Gay, Bisexual, and Transgender–Related Content in Undergraduate Medical EducationJAMA, 2011